Researchers find high cardiovascular risk even in normal weight individuals

April 04, 2017

A new research study has found that approximately one-third of all individuals with a normal body mass index (BMI) had cardio-metabolic risk factors for heart disease, especially those of South Asian and Hispanic descent.

Based on these findings, the research team, from Emory University, the University of California at San Francisco and Northwestern University, recommends cardiometabolic (heart disease or diabetes risk) screenings in members of race/ethnic minority populations, even prior to the onset of overweight or obesity.

Researchers studied 2,622 white Americans, 1,893 African Americans, 1,496 Hispanic Americans, 803 Chinese Americans, and 803 South Asian Americans aged 44 to 84 years to determine how many people with a normal body weight had risk factors for heart disease or diabetes (also known as cardiometabolic risk factors), and if those rates differed among racial/ethnic groups.

"The key message for clinicians is that using overweight and obesity as the main criteria to screen for high blood pressure, high glucose, high triglycerides, or low HDL cholesterol will likely miss a substantial number of people who have high cardiometabolic risk but are of normal weight," says first author Unjali Gujral, PhD, from the Emory Global Diabetes Research Center at Rollins School of Public Health.

"Therefore, while the United States Preventive Services Task Force recommends screening at younger ages in racial/ethnic minority groups, testing for cardiometabolic abnormalities in normal-weight and underweight members of these groups may also be an important consideration."
-end-
Complete findings are published in the April 3rd edition of the Annals of Internal Medicine.

Emory Health Sciences

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.